Medication abortion during the COVID-19 pandemic in France: A research based on the French national health insurance database.

Objectives: During the COVID-19 pandemic in France, abortion was recognized as an essential service that cannot be delayed, and such care was therefore presumed to be maintained. The aim is to analyze the changes in the practice of abortion in 2020 to identify the consequences of the two lockdowns and the effects of the extension of the legal time limit.

Methods: We analyzed the data collected by the French national health insurance system, which covers 99% of the population.

The COVID-19 crisis and ART activity in France.

Research Question: What was the impact of the COVID-19 pandemic on assisted reproductive technology (ART) activity in public and private hospitals in France in 2020?

Design: All women who underwent oocyte retrieval in 2020 (study group, n = 40,759) or in 2019 (comparison group, n = 52,403) were selected from French national health insurance databases. The weekly ART activity in 2020 was compared with the weekly ART activity in 2019.

Results: In 2020, annual ART activity dropped by nearly 30% compared with 2019.